EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 38 / No 3 (September 2006) J Extra Corpor Technol, 38 3 (2006) 230-234 References
Free Access
Issue
J Extra Corpor Technol
Volume 38, Number 3, September 2006
Page(s) 230 - 234
DOI https://doi.org/10.1051/ject/200638230
Published online 15 September 2006
  1. Hilt T, Bayat M. Drugs used to limit blood surface interactions. Crit Care Nurs Clin North Am. 2002;14:7–16. [CrossRef] [Google Scholar]
  2. Bick RL, Frenkel EP, Walenga J, Fareed J, Hoppensteadt DA. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: Basic mechanism of actions, pharmacology, and clinical use. Hematol Oncol Clin North Am. 2005;19:1–51. [CrossRef] [Google Scholar]
  3. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials. 2004;25:5681–703. [CrossRef] [Google Scholar]
  4. Poncz M. Mechanistic basis of heparin-induced thrombocytopenia. Semin Thorac Cardiovasc Surg. 2005;17:73–9. [CrossRef] [Google Scholar]
  5. Tendera M, Wojakowski W. Role of antiplatelet drugs in the prevention of cardiovascular events. Thromb Res. 2003;15:355–9. [CrossRef] [Google Scholar]
  6. Tamberella MR, Furman MI. The role of platelet inhibition in the drug-eluting stent era. Coron Artery Dis. 2004;15:327–9. [CrossRef] [PubMed] [Google Scholar]
  7. Koster A, Fischer T, Gruendel M, et al. Management of heparin resistance during cardiopulmonary bypass: The effect of five different anticoagulation strategies on hemostatic activation. J Cardiothorac Vasc Anesth. 2003;17:171–5. [CrossRef] [Google Scholar]
  8. Kaufman JS, O’Connor TZ, Zhang JH, et al. Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J Am Soc Nephrol. 2003;14:2313–21. [CrossRef] [PubMed] [Google Scholar]
  9. Sukavaneshvar S, Zheng Y, Rosa GM, Mohammad SF, Solen KA. Thromboembolization associated with sudden increases in flow in a coronary stent ex vivo shunt model. ASAIO J. 2000;46:301–4. [CrossRef] [PubMed] [Google Scholar]
  10. Solen K, Sukavaneshvar S, Zheng Y, et al. Light-scattering instrument to detect thromboemboli in blood. J Biomed Opt. 2003;8:70–9. [CrossRef] [Google Scholar]
  11. Sukavaneshvar S, Solen KA, Mohammad SF. An in-vitro model to study device-induced thrombosis and embolism: evaluation of the efficacy of Tirofiban, aspirin, and dipyridamole. Thromb Haemost. 2000;83:322–6. [CrossRef] [PubMed] [Google Scholar]
  12. Nollert G, Reichart B. Cardiopulmonary bypass and cerebral injury in adults. Shock. 2001;16(Suppl 1):16–9. [CrossRef] [PubMed] [Google Scholar]
  13. Raymond PD, Marsh NA. Alterations to haemostasis following cardiopulmonary bypass and the relationship of these changes to neurocognitive morbidity. Blood Coagul Fibrinolysis. 2001;12:601–18. [CrossRef] [PubMed] [Google Scholar]
  14. Mezzano D, Tagle R, Panes O, et al. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis. Thromb Haemost. 1996;76:312–21. [CrossRef] [PubMed] [Google Scholar]
  15. Cattaneo M. Aspirin and clopidogrel: efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol. 2004;24:1980–7. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.